0002085914-26-000002.txt : 20261027 0002085914-26-000002.hdr.sgml : 20261027 20261027105449 ACCESSION NUMBER: 0002085914-26-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20261027 DATE AS OF CHANGE: 20261027 EFFECTIVENESS DATE: 20261027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bioaxia Life Sciences Fund LP CENTRAL INDEX KEY: 0002085914 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-557477 FILM NUMBER: 261488319 BUSINESS ADDRESS: STREET 1: 455 10TH AVENUE, PH2G CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 617-999-5008 MAIL ADDRESS: STREET 1: 455 10TH AVENUE, PH2G CITY: NEW YORK STATE: NY ZIP: 10018 D/A 1 primary_doc.xml X0708 D/A LIVE 0002085914 Bioaxia Life Sciences Fund LP 455 10TH AVENUE PH2G NEW YORK NY NEW YORK 10018 617-999-5008 DELAWARE None None Limited Partnership true 2025 n/a Bioaxia Life Sciences Fund GP LLC 455 10th Avenue PH2G New York NY NEW YORK 10018 Executive Officer Promoter General Partner of the Issuer n/a Bioaxia LLC 455 10th Avenue PH2G New York NY NEW YORK 10018 Executive Officer Promoter Investment Manager of the Issuer Douglas Eby 455 10th Avenue PH2G New York NY NEW YORK 10018 Executive Officer Managing Member of the General Partner of the Issuer Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0002085914-25-000001 2025-09-30 true true true false 500000 N/A None None None N/A N/A N/A XX Unknown 00000 All States false Indefinite 3260000 Indefinite false 6 0 0 0 true The fund charges a management fee that is described in the fund's governing documents. false Bioaxia Life Sciences Fund LP /s/ Douglas Eby Douglas Eby Managing Member of the General Partner of the Issuer 2026-10-27